Literature DB >> 28609171

Myocardial performance index in hypertensive disorders of pregnancy: The relationship between blood pressures and angiogenic factors.

Hadi Ramadan1, Sarosh Rana1, Ariel Mueller2, Surichhya Bajracharya3, Dongsheng Zhang3, Saira Salahuddin3, Rabab Nasim1, Joana Lopes Perdigao1, Mohammed Minhaj4, Avery Tung4, Zolt Arany5, Sajid Shahul4.   

Abstract

OBJECTIVE: To study the association between cardiac function measured by myocardial performance index (MPI), blood pressures and angiogenic factors measured at the time of echocardiography in patients with and without hypertensive disorders of pregnancy (HDP).
METHODS: We prospectively studied 189 pregnant women and evaluated whether changes in cardiac function observed on echocardiography were correlated with higher blood pressures and whether higher blood pressures were associated with antiangiogenic proteins (soluble fms-like tyrosine kinase, sFlt1; soluble endoglin, sEng). Comprehensive echocardiograms, including measurement of MPI, were performed on all patients. sFlt1 and sEng levels were measured using enzyme-linked immunosorbent assay.
RESULTS: Overall, 189 patients were divided into tertiles based on mean arterial pressure (MAP). The MPI was worst in tertile 3 (0.50 ± 0.15) compared to tertile 1 (0.42 ± 0.10), p = 0.0004. sFlt1 (pg/ml) and sEng (ng/ml) were highest in tertile 3 compared to tertile 1: 15055.37 vs. 1623.01 and 33.06 vs. 8.15, respectively, with p-value <0.001. In crude multivariate regression analysis, MAP was positively correlated with MPI (r = 0.32, p < 0.001), GLS (r = 0.54, p < 0.001), sFlt1 (r = 0.60, p < 0.001) and sEng (r = 0.61, p < 0.001). After adjustment for confounders, these relationships persisted between MAP and MPI (r = 0.31, p = 0.0003), GLS (r = 0.46, p < 0.001), sFlt1 (r = 0.56, p < 0.001) and sEng (r = 0.58, p < 0.001).
CONCLUSION: Mean arterial pressure correlates with worsening cardiac function as measured by MPI and serum levels of angiogenic factors. Further studies are needed to evaluate whether a reduction in blood pressure will reverse changes in MPI or reduce levels of angiogenic proteins seen among women with HDP.

Entities:  

Keywords:  Mean arterial pressure; angiogenic factors; global longitudinal strain; myocardial performance index; pregnancy

Mesh:

Substances:

Year:  2017        PMID: 28609171      PMCID: PMC5949867          DOI: 10.1080/10641955.2017.1280048

Source DB:  PubMed          Journal:  Hypertens Pregnancy        ISSN: 1064-1955            Impact factor:   2.108


  28 in total

1.  The Tei index - a role in the diagnosis of heart failure?

Authors:  M St John Sutton; S E Wiegers
Journal:  Eur Heart J       Date:  2000-11       Impact factor: 29.983

2.  Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

Authors:  N G Bellenger; M I Burgess; S G Ray; A Lahiri; A J Coats; J G Cleland; D J Pennell
Journal:  Eur Heart J       Date:  2000-08       Impact factor: 29.983

3.  Soluble endoglin contributes to the pathogenesis of preeclampsia.

Authors:  Shivalingappa Venkatesha; Mourad Toporsian; Chun Lam; Jun-ichi Hanai; Tadanori Mammoto; Yeon M Kim; Yuval Bdolah; Kee-Hak Lim; Hai-Tao Yuan; Towia A Libermann; Isaac E Stillman; Drucilla Roberts; Patricia A D'Amore; Franklin H Epstein; Frank W Sellke; Roberto Romero; Vikas P Sukhatme; Michelle Letarte; S Ananth Karumanchi
Journal:  Nat Med       Date:  2006-06-04       Impact factor: 53.440

4.  Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology.

Authors:  Roberto M Lang; Michelle Bierig; Richard B Devereux; Frank A Flachskampf; Elyse Foster; Patricia A Pellikka; Michael H Picard; Mary J Roman; James Seward; Jack S Shanewise; Scott D Solomon; Kirk T Spencer; Martin St John Sutton; William J Stewart
Journal:  J Am Soc Echocardiogr       Date:  2005-12       Impact factor: 5.251

5.  Maternal cardiac dysfunction and remodeling in women with preeclampsia at term.

Authors:  Karen Melchiorre; George Ross Sutherland; Aigul Baltabaeva; Marco Liberati; Basky Thilaganathan
Journal:  Hypertension       Date:  2010-11-22       Impact factor: 10.190

6.  Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension.

Authors:  B C Aeschbacher; D Hutter; J Fuhrer; P Weidmann; E Delacrétaz; Y Allemann
Journal:  Am J Hypertens       Date:  2001-02       Impact factor: 2.689

7.  Echoventriculography -- a simultaneous analysis of two-dimensional echocardiography and cineventriculography.

Authors:  R Erbel; P Schweizer; H Lambertz; G Henn; J Meyer; W Krebs; S Effert
Journal:  Circulation       Date:  1983-01       Impact factor: 29.690

Review 8.  Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy.

Authors:  Jennifer A Hutcheon; Sarka Lisonkova; K S Joseph
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2011-02-18       Impact factor: 5.237

9.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.

Authors:  Sharon E Maynard; Jiang-Yong Min; Jaime Merchan; Kee-Hak Lim; Jianyi Li; Susanta Mondal; Towia A Libermann; James P Morgan; Frank W Sellke; Isaac E Stillman; Franklin H Epstein; Vikas P Sukhatme; S Ananth Karumanchi
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

10.  Relation of transmitral flow velocity patterns to left ventricular diastolic function: new insights from a combined hemodynamic and Doppler echocardiographic study.

Authors:  C P Appleton; L K Hatle; R L Popp
Journal:  J Am Coll Cardiol       Date:  1988-08       Impact factor: 24.094

View more
  1 in total

Review 1.  Long-Term Cardiovascular Disease Risk in Women After Hypertensive Disorders of Pregnancy: Recent Advances in Hypertension.

Authors:  Kavia Khosla; Sarah Heimberger; Kristin M Nieman; Avery Tung; Sajid Shahul; Anne Cathrine Staff; Sarosh Rana
Journal:  Hypertension       Date:  2021-08-15       Impact factor: 10.190

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.